Clinical trial
Cervical Cancer Early Endpoints and Determinants
NCT00339989 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00339989 |
|---|---|
| Title | Cervical Cancer Early Endpoints and Determinants |
| Official title | A Study to Understand Cervical Cancer Early Endpoints and Determinants (SUCCEED) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Cervical Cancer, Cervical Intraepithelial, Neoplasia, CIN |
| Enrollment | 3,013 |
| Start date | Sep 12, 2003 |
| Primary completion | Apr 15, 2015 |
| Completion | Mar 11, 2020 |
| First posted | Jun 21, 2006 |
| Last update posted | Mar 13, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: